{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:03:23Z","timestamp":1781129003298,"version":"3.54.1"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"am","delay-in-days":334,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019706","name":"QBRI","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019706","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["18dk0207030h0003"],"award-info":[{"award-number":["18dk0207030h0003"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP23dm0207073"],"award-info":[{"award-number":["JP23dm0207073"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jns-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the Neurological Sciences"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.jns.2023.120760","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T11:19:51Z","timestamp":1690888791000},"page":"120760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["IgG index of cerebrospinal fluid can reflect pathophysiology associated with Lewy bodies in Parkinson's disease"],"prefix":"10.1016","volume":"452","author":[{"given":"Hidetomo","family":"Murakami","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiko","family":"Tokuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar M.A.","family":"El-Agnaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuma","family":"Ohmichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mizuki","family":"Kanemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamao","family":"Tsukie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ikeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenjiro","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jns.2023.120760_bb0005","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/bs.pmbts.2020.11.001","article-title":"Inflammation and Parkinson\u2019s disease pathogenesis: mechanisms and therapeutic insight","volume":"177","author":"Forloni","year":"2021","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"10.1016\/j.jns.2023.120760_bb0010","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.pneurobio.2015.07.003","article-title":"Protein aggregation and neurodegeneration in prototypical neurodegenerative diseases: examples of amyloidopathies, tauopathies and synucleinopathies","volume":"155","author":"Bourdenx","year":"2017","journal-title":"Prog. Neurobiol."},{"issue":"12","key":"10.1016\/j.jns.2023.120760_bb0015","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1212\/WNL.0b013e3181d5a4a3","article-title":"Anti-inflammatory drugs and risk of Parkinson disease: a meta-analysis","volume":"74","author":"Gagne","year":"2010","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.jns.2023.120760_bb0020","first-page":"112","article-title":"CSF evaluation in neurologic disease","volume":"35","author":"El-Mallakh","year":"1987","journal-title":"Am. Fam. Physician"},{"issue":"12","key":"10.1016\/j.jns.2023.120760_bb0025","doi-asserted-by":"crossref","first-page":"3362","DOI":"10.1007\/s11064-017-2382-x","article-title":"The oligomer hypothesis in \u03b1-Synucleinopathy","volume":"42","author":"Ono","year":"2017","journal-title":"Neurochem. Res."},{"issue":"8","key":"10.1016\/j.jns.2023.120760_bb0030","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1007\/s00259-019-04480-8","article-title":"Diagnostic accuracy of DAT-SPECT and MIBG scintigraphy for dementia with Lewy bodies: an updated systematic review and Bayesian latent class model meta-analysis","volume":"47","author":"Nihashi","year":"2020","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"1","key":"10.1016\/j.jns.2023.120760_bb0035","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12883-019-1346-y","article-title":"Correlated levels of cerebrospinal fluid pathogenic proteins in drug-na\u00efve Parkinson's disease","volume":"19","author":"Murakami","year":"2019","journal-title":"BMC Neurol."},{"issue":"11","key":"10.1016\/j.jns.2023.120760_bb0040","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1007\/s00259-014-2841-4","article-title":"Do CSF levels of t-tau, p-tau and \u03b2\u2081\u208b\u2084\u2082 amyloid correlate with dopaminergic system impairment in patients with a clinical diagnosis of Parkinson disease? A 123I-FP-CIT study in the early stages of the disease","volume":"41","author":"Chiaravalloti","year":"2014","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"issue":"20","key":"10.1016\/j.jns.2023.120760_bb0045","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1212\/WNL.0b013e3181fd613b","article-title":"Detection of elevated levels of \u03b1-synuclein oligomers in CSF from patients with Parkinson disease","volume":"75","author":"Tokuda","year":"2010","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.jns.2023.120760_bb0050","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1002\/mds.28611","article-title":"Cerebrospinal \u03b1-Synuclein oligomers reflect disease motor severity in DeNoPa longitudinal cohort","volume":"36","author":"Majbour","year":"2021","journal-title":"Mov. Disord."},{"issue":"3","key":"10.1016\/j.jns.2023.120760_bb0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/ana.25811","article-title":"Parkinson\u2019s progression marker initiative, evolution of Alzheimer\u2019s disease cerebrospinal fluid biomarkers in early Parkinson\u2019s disease","volume":"88","author":"Irwin","year":"2020","journal-title":"Ann. Neurol."},{"issue":"12","key":"10.1016\/j.jns.2023.120760_bb0060","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"issue":"5","key":"10.1016\/j.jns.2023.120760_bb0065","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1212\/WNL.17.5.427","article-title":"Parkinsonism: onset, progression and mortality","volume":"17","author":"Hoehn","year":"1967","journal-title":"Neurology"},{"key":"10.1016\/j.jns.2023.120760_bb0070","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3389\/fnagi.2017.00321","article-title":"Accumulation of 123I-Ioflupane is a useful marker of the efficacy of Selegiline monotherapy in drug-Na\u00efve Parkinson\u2019s disease","volume":"9","author":"Murakami","year":"2017","journal-title":"Front. Aging Neurosci."},{"issue":"8","key":"10.1016\/j.jns.2023.120760_bb0075","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1002\/gps.4229","article-title":"Diagnostic value of MIBG cardiac scintigraphy for differential dementia diagnosis","volume":"30","author":"Slaets","year":"2015","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.jns.2023.120760_bb0080","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jchemneu.2017.06.005","article-title":"Immunomodulation of Parkinson's disease using Mucuna pruriens (Mp)","volume":"85","author":"Rai","year":"2017","journal-title":"J. Chem. Neuroanat."},{"issue":"1","key":"10.1016\/j.jns.2023.120760_bb0085","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/s40478-017-0494-9","article-title":"\u03b1-Synuclein fibrils recruit peripheral immune cells in the rat brain prior to neurodegeneration","volume":"5","author":"Harms","year":"2017","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.jns.2023.120760_bb0090","doi-asserted-by":"crossref","first-page":"4836","DOI":"10.1007\/s00415-022-11120-z","article-title":"REM sleep behavior disorder and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau and phosphorylated tau in Parkinson's disease: a cross-sectional and longitudinal study","volume":"269","author":"Nabizadeh","year":"2022","journal-title":"J. Neurol."},{"issue":"2","key":"10.1016\/j.jns.2023.120760_bb0095","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s10072-022-06440-x","article-title":"Longitudinal striatal dopamine transporter binding and cerebrospinal fluid alpha-synuclein, amyloid beta, total tau, and phosphorylated tau in Parkinson's disease","volume":"44","author":"Nabizadeh","year":"2023","journal-title":"Neurol. Sci."},{"issue":"4","key":"10.1016\/j.jns.2023.120760_bb0100","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.ajpath.2013.12.007","article-title":"Parkinson study group DATATOP investigators, cerebrospinal fluid \u03b1-synuclein predicts cognitive decline in Parkinson disease progression in the DATATOP cohort","volume":"184","author":"Stewart","year":"2014","journal-title":"Am. J. Pathol."},{"issue":"9","key":"10.1016\/j.jns.2023.120760_bb0105","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1002\/mds.27806","article-title":"PPMI study, longitudinal analyses of cerebrospinal fluid \u03b1-Synuclein in prodromal and early Parkinson\u2019s disease","volume":"34","author":"Mollenhauer","year":"2019","journal-title":"Mov. Disord."},{"key":"10.1016\/j.jns.2023.120760_bb0110","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fneur.2018.00809","article-title":"Tau pathology in Parkinson\u2019s disease","volume":"9","author":"Zhang","year":"2018","journal-title":"Front. Neurol."},{"issue":"10","key":"10.1016\/j.jns.2023.120760_bb0115","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1093\/brain\/awac171","article-title":"Tau accelerates \u03b1-synuclein aggregation and spreading in Parkinson's disease","volume":"145","author":"Pan","year":"2022","journal-title":"Brain"},{"issue":"13","key":"10.1016\/j.jns.2023.120760_bb0120","doi-asserted-by":"crossref","first-page":"7307","DOI":"10.3390\/ijms23137307","article-title":"Tau as a biomarker of neurodegeneration","volume":"23","author":"Holper","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.jns.2023.120760_bb0125","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/S1474-4422(21)00061-2","article-title":"Progress towards therapies for disease modification in Parkinson's disease","volume":"20","author":"Vijiaratnam","year":"2021","journal-title":"Lancet Neurol."}],"container-title":["Journal of the Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022510X23002216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:28:59Z","timestamp":1777422539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022510X23002216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":25,"alternative-id":["S0022510X23002216"],"URL":"https:\/\/doi.org\/10.1016\/j.jns.2023.120760","relation":{},"ISSN":["0022-510X"],"issn-type":[{"value":"0022-510X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG index of cerebrospinal fluid can reflect pathophysiology associated with Lewy bodies in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Journal of the Neurological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jns.2023.120760","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"120760"}}